CONTENTS
Recent Posts
- Amring Pharmaceuticals Inc. Joins End Drug Shortages Alliance
- Amring Pharmaceuticals Inc. Announces the Launch of Timolol Maleate Ophthalmic Solution, USP 0.5%
- Amring Pharmaceuticals Inc. Announces the Approval and Launch of Generic Lamotrigine Orally Disintegrating Tablets (ODT), USP
- Amzell B.V. and Amring Pharmaceuticals Inc. Attending 2021 American Epilepsy Society Meeting
- Amzell, B.V., in Collaboration with Amring Pharmaceuticals Inc. Announce Their Lead Product has Entered Phase III Clinical Trial in the U.S. for Treatment of Infantile Epileptic Disease
Recent Comments